Akoya Biosciences, Inc. (AKYA) Research

Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions. The company's mission is to significantly advance both discovery and clinical research across numerous global regions, including North America, Asia Pacific, Europe, the Middle East, and Africa. Their core product lineup features the PhenoCycler instrument, a compact benchtop fluidics system designed to integrate seamlessly with a microscope for automated image acquisition. Complementing this is the PhenoImager platform, which empowers researchers to intricately visualize, analyze, quantify, and characterize cells directly within diverse tissue samples—such as fresh frozen or FFPE sections and tissue microarrays—through an efficient, automated, and high-throughput process. Akoya also supplies the essential reagents for these PhenoCycler and PhenoImager systems, alongside providing specialized biopharmaceutical services. Beyond hardware, Akoya offers a robust suite of software tools. Proxima serves as a cloud-based platform for the secure storage, comprehensive analysis, and collaborative sharing of spatial data. For image interpretation, the inForm Tissue software delivers automated analysis to precisely visualize and quantify biomarkers within tissue sections. Further streamlining data workflows, Phenoptr facilitates the consolidation and in-depth analysis of output tables generated by inForm. Finally, phenoptrReports is a user-friendly software application that generates intuitive reports and visualizations from phenoptr output, presented via an easy-to-navigate graphical user interface. Established in 2015, Akoya Biosciences maintains its corporate headquarters in Marlborough, Massachusetts.

Market snapshot

Symbol
AKYA
Price
$1.29
Day change
-5.15%
Market cap
$64.4M
P/E ratio
-2.69x
52-week range
0.931-3.42
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Analyst price target
$4.98

Peer companies

  • Achilles Therapeutics plc (ACHL)
  • Heat Biologics, Inc. (HTBX)
  • Lifeward Ltd. (LFWD)
  • NeueHealth, Inc. (NEUE)
  • Singular Genomics Systems, Inc. (OMIC)
  • Reneo Pharmaceuticals, Inc. (RPHM)
  • Sigilon Therapeutics, Inc. (SGTX)
  • Surface Oncology, Inc. (SURF)

Recent insider activity

  • Mendel Scott — J-Other (28500 shares) on 2025-07-08
  • Mendel Scott — J-Other (35562 shares) on 2025-07-08
  • Mendel Scott — J-Other (30549 shares) on 2025-07-08
  • Mendel Scott — J-Other (56322 shares) on 2025-07-08
  • Mendel Scott — J-Other (50000 shares) on 2025-07-08

Open Akoya Biosciences, Inc. (AKYA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.